Liu Dan of Pivotal Bioventure Capital: China's New Drug BD Global Share to Keep Rising, Shift Focus from "Transaction Volume" to "Cooperation Quality" | Medical Outlook 2026 - 36 Kr

2026-03-02 - 02:03

Liu Dan of Pivotal Bioventure Capital: China's New Drug BD Global Share to Keep Rising, Shift Focus from "Transaction Volume" to "Cooperation Quality" | Medical Outlook 2026 36 Kr